Synthesis and biological evaluation of 7-azaindolocarbazoles

Add time:08/10/2019    Source:sciencedirect.com

In the course of a program aimed at designing antitumor agents containing an indolocarbazole framework, an efficient synthetic scheme based on the use of 3,4-dibromo-N-methylmaleimide and 7-azaindole has been developed to elaborate a series of mono- and di-aza derivatives of arcyriaflavin. The procedure was further exploited to introduce a hydroxyl group at different positions on the indole moiety of the non-symmetrical compounds. The DNA binding capacity and cytotoxic potential of these 7-azaindolocarbazole derivatives was evaluated.

We also recommend Trading Suppliers and Manufacturers of 7-BENZHYDRYLOXYINDOLE (cas 135328-49-3). Pls Click Website Link as below: cas 135328-49-3 suppliers

Prev:Randomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for oral stepdown clarithromycin for treatment of patients with mild to moderate community-acquired pneumonia requiring hospitalization
Next:diazipine (cas 135330-18-6), a novel photoaffinity probe for dihydropyridine receptors of calcium channels)